These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17929434)

  • 1. [The possibility and limitations of cell therapy. 2) The current status and overview of tumor-immune cell therapy--T cell-dendritic cell therapy].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1923-8. PubMed ID: 17929434
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
    Fan J; Shang D; Han B; Song J; Chen H; Yang JM
    Theranostics; 2018; 8(20):5784-5800. PubMed ID: 30555581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the dendritic cell: the key to immunotherapy in cancer?
    Faith A; Hawrylowicz CM
    Clin Exp Immunol; 2005 Mar; 139(3):395-7. PubMed ID: 15730383
    [No Abstract]   [Full Text] [Related]  

  • 4. The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity.
    Park MY; Kim CH; Sohn HJ; Oh ST; Kim SG; Kim TG
    Vaccine; 2007 Oct; 25(42):7322-30. PubMed ID: 17889413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy.
    Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS
    Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunotherapy of cancer: an overview and future directions.
    Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S
    Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties of dendritic cells: implications to their use in the treatment of cancer.
    van Schooten WC; Strang G; Palathumpat V
    Mol Med Today; 1997 Jun; 3(6):254-60. PubMed ID: 9211416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of acquired tolerance to cardiac allografts by adoptive transfer of in vivo allopeptide activated T cells.
    Ali AO; Garrovillo M; Oluwole OO; DePaz HA; Gopinathan R; Hardy MA; Oluwole SF
    Transplant Proc; 2001; 33(1-2):97. PubMed ID: 11266725
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory role of the thymic dendritic cells in acquired thymic tolerance: induction of tolerance to cardiac allografts by adoptive transfer of allopeptide-pulsed host thymic dendritic cells.
    Garrovillo M; Ali AO; DePaz HA; Gopinathan R; Oluwole OO; Hardy MA; Oluwole SF
    Transplant Proc; 2001; 33(1-2):149. PubMed ID: 11266752
    [No Abstract]   [Full Text] [Related]  

  • 11. Dendritic cells and T cells in immunotherapy.
    O'Neill DW
    J Drugs Dermatol; 2010 Nov; 9(11):1383-92. PubMed ID: 21061761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based tumor immunotherapy.
    Kadowaki N; Kitawaki T
    Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective ex vivo expansion of cytomegalovirus-specific CD4+ and CD8+ T lymphocytes using dendritic cells pulsed with a human leucocyte antigen A*0201-restricted peptide.
    Vannucchi AM; Glinz S; Bosi A; Caporale R; Rossi-Ferrini P
    Br J Haematol; 2001 May; 113(2):479-82. PubMed ID: 11380419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma.
    Shimizu K; Kotera Y; Aruga A; Takeshita N; Takasaki K; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):171-8. PubMed ID: 21874278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A
    Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in multiple myeloma--possibility or probability?
    Harrison SJ; Cook G
    Br J Haematol; 2005 Aug; 130(3):344-62. PubMed ID: 16042684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From dendritic cells to the exosomes that they secrete: a decisive advance for anticancer vaccine therapy?].
    Jeanteur P
    Bull Cancer; 1998 Jun; 85(6):521. PubMed ID: 9752278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.